Authors
Latest:
Tackling the challenge of noninfectious uveitisChronic cases can be difficult for retinal specialists, but treatment is satisfying.
Latest:
Navigating the COVID-19 pandemic with ophthalmic patients in the hospital settingNew operating procedures ensure eye clinics can operate safely amid virus.
Latest:
BLOG: The PTVT Trial and Clinical ApplicationsJoseph F. Panarelli MD, Steven J. Gedde, MD, and Vikram Paranjpe MD, MPH discuss the Primary Tube Versus Trabeculectomy (PTVT) study.
Latest:
The Impressions and Takeaways from Patient Case No. 2An expert underscores the importance of a comprehensive dry eye examination and offers insights on distinguishing it from neurotrophic keratitis.
Latest:
The path forward for oculomics and AIThe AI-READI project aims to establish fair, equitable, and ethical access to big data, enhancing artificial intelligence’s ability to diagnose systemic diseases and drive progress in ophthalmology research.
Latest:
New presbyopia-correcting IOL provides spectacle independenceLens combines diffractive multifocal and extended depth-of-focus properties.
Latest:
Assessing the quality of real-world evidence in retinal diseasesReal-world evidence is growing in importance as a source of information that can help support clinical decision-making when evaluated properly.
Latest:
The ABCs of canaloplastyNot only is canaloplasty designed to treat the entire conventional outflow pathway, facilitating flow through the trabecular meshwork, Schlemm canal, and collector channels, but it does so without a stent and without removing tissue.
Latest:
Envision Summit 2025: How to use the new G2211 codeAt the Envision Summit 2025 in San Juan, Puerto Rico, Lana Rifkin, MD, gave clinicians advice on how, and when it may be most appropriate to use the new G2211 code.
Latest:
Pigskins and perception: How neuro-ophthalmology influences NFL refereesEvery football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.
Latest:
Envision Summit 2025: Surgical challenges of a pediatric retinal detachment secondary to traumaAt the Envision Summit 2025 in San Juan, Puerto Rico, Nita Valikodath, MD, MS, gave insight into a challenging case of a 14-year-old boy who had trauma-related retinal detachment in his right eye, where a further macula-on retinal detachment with retinal dialysis was found in the left.
Latest:
Seeking a solution to the anesthesia provider shortageOffice-based surgery could prove to be a viable option for physicians.
Latest:
Future of Intravitreal InjectionNadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
The relationship between myopia and conjunctival-scleral geometryNasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
Latest:
New IOLs for keratoconus and other aberrated corneasAnterior segment surgeon expands on the use of the XtraFocus pinhole implant.
Latest:
Focus on molecular mechanisms underlying cataract developmentSeveral hundred genes are associated with congenital forms.
Latest:
What ophthalmologists need to know about neuromyelitis optica spectrum disorderEarly diagnosis of NMOSD is key to preventing disability, improving survival.
Latest:
Electrical neurostimulation for glaucoma with Sunita Radhakrishnan, MDSunita Radhakrishnan, MD, shares insights on the use of electric neurostimulation and its potential use in the treatment of glaucoma, as evidenced by its current use in Europe and the upcoming trials for use in the US.
Latest:
Froin syndrome: Eyes are the window to the spinePapilledema with back pain suggests spine lesion.
Latest:
Dropless cataract surgery: Shifting paradigm in postoperative careRemoving drops from procedure increases adherence and comfort for most patients.
Latest:
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)ENTOD Pharmaceuticals launches Myatro XL, a 0.05% atropine eye drop, to effectively slow myopia progression in children, available by prescription in 2025.
Latest:
Toric stability: A minor change with a major impact for patientsLens offering surgeons a reassuring amount of resistance to movement in the eye
